| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.2B | $16.7B | $15.4B | $14.4B | $13.7B | $12.3B | $11.1B | $10.2B |
| Cost of Revenue | $14.1B | $13.9B | $13.2B | $12.3B | $11.7B | $10.6B | $9.5B | $8.7B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| SG&A Expense | $1.0B | $1.0B | $0.9B | $0.9B | $0.9B | $0.8B | $0.7B | $0.7B |
| Operating Income | $2.1B | $1.8B | $0.6B | $1.1B | $1.2B | $1.0B | $0.9B | $0.7B |
| Net Income | $1.4B | $1.3B | $0.2B | $0.7B | $0.8B | $0.6B | $0.7B | $0.6B |
| EPS (Basic) | $11.31 | $9.36 | $1.45 | $5.00 | $5.34 | $4.42 | $4.66 | $3.85 |
| EPS (Diluted) | $11.14 | $9.22 | $1.44 | $4.96 | $5.27 | $4.36 | $4.60 | $3.80 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.5B | $13.1B | $12.7B | $13.1B | $13.3B | $12.5B | $9.4B | $8.8B |
| Current Assets | $4.8B | $4.4B | $4.0B | $3.6B | $3.6B | $3.3B | $2.8B | $2.8B |
| Cash & Equivalents | $1.1B | $0.9B | $0.8B | $0.5B | $0.7B | $0.5B | $0.7B | $0.3B |
| Total Liabilities | $8.5B | $8.6B | $8.4B | $8.7B | $8.9B | — | — | — |
| Current Liabilities | $2.8B | $3.7B | $3.0B | $3.9B | $3.2B | $2.9B | $2.3B | $2.1B |
| Stockholders' Equity | $4.9B | $4.4B | $4.2B | $4.3B | $4.3B | $3.9B | $3.4B | $3.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.4B | $1.2B | $1.0B | $1.0B | $1.3B | $1.0B | — |
| Investing Cash Flow | $-0.4B | $-0.1B | $-0.2B | $-0.3B | $-0.7B | $-2.8B | $0.1B | — |
| Capital Expenditures | — | — | — | — | — | — | $0.1B | $0.1B |
| Financing Cash Flow | $-1.1B | $-1.1B | $-0.7B | $-0.9B | $-0.1B | $1.5B | $-0.7B | — |